Haploinsufficiency of the Primary Familial Brain Calcification Gene SLC20A2 Mediated by Disruption of a Regulatory Element.
CNV
SLC20A2
enhancer
primary familial brain calcification
regulation
Journal
Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
10
12
2019
revised:
17
01
2020
accepted:
03
04
2020
pubmed:
9
6
2020
medline:
28
4
2021
entrez:
8
6
2020
Statut:
ppublish
Résumé
Primary familial brain calcification (PFBC) is a rare cerebral microvascular calcifying disorder with diverse neuropsychiatric expression. Five genes were reported as PFBC causative when carrying pathogenic variants. Haploinsufficiency of SLC20A2, which encodes an inorganic phosphate importer, is a major cause of autosomal-dominant PFBC. However, PFBC remains genetically unexplained in a proportion of patients, suggesting the existence of additional genes or cryptic mutations. We analyzed exome sequencing data of 71 unrelated, genetically unexplained PFBC patients with the aim to detect copy number variations that may disrupt the expression of core PFBC-causing genes. After the identification of a deletion upstream of SLC20A2, we assessed its consequences on gene function by reverse transcriptase droplet digital polymerase chain reaction (RT-ddPCR), an ex vivo inorganic phosphate uptake assay, and introduced the deletion of a putative SLC20A2 enhancer mapping to this region in human embryonic kidney 293 (HEK293) cells by clustered regularly interspaced short palindromic repeats (CRISPR) - CRISPR-associated protein 9 (Cas9). The 8p11.21 deletion, segregating with PFBC in a family, mapped 35 kb upstream of SLC20A2. The deletion carriers/normal controls ratio of relative SLC20A2 mRNA levels was 60.2% (P < 0.001). This was comparable with that of patients carrying an SLC20A2 premature stop codon (63.4%; P < 0.001). The proband exhibited a 39.3% decrease of inorganic phosphate uptake in blood (P = 0.015). In HEK293 cells, we observed a 39.8% decrease in relative SLC20A2 mRNA levels after normalization on DNA copy number (P < 0.001). We identified a deletion of an enhancer of SLC20A2 expression, with carriers showing haploinsufficiency in similar ranges to loss-of-function alleles, and we observed reduced mRNA levels after deleting this element in a cellular model. We propose a 3-step strategy to identify and easily assess the effect of such events. © 2020 International Parkinson and Movement Disorder Society.
Substances chimiques
SLC20A2 protein, human
0
Sodium-Phosphate Cotransporter Proteins, Type III
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1336-1345Informations de copyright
© 2020 International Parkinson and Movement Disorder Society.
Références
Wawrocka A, Krawczynski MR. The genetics of aniridia-simple things become complicated. J Appl Genet 2018;59:151-159.
Bhatia S, Bengani H, Fish M, et al. Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. Am J Hum Genet 2013;93:1126-1134.
Lettice LA, Heaney SJH, Purdie LA, et al. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet 2003;12:1725-1735.
Short PJ, McRae JF, Gallone G, et al. De novo mutations in regulatory elements in neurodevelopmental disorders. Nature 2018;555:611-616.
Kellis M, Wold B, Snyder MP, et al. Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A 2014;111:6131-6138.
Visel A, Minovitsky S, Dubchak I, Pennacchio LA. VISTA Enhancer Browser-a database of tissue-specific human enhancers. Nucleic Acids Res 2007;35:D88-D92.
The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
Zerbino DR, Achuthan P, Akanni W, et al. Ensembl 2018. Nucleic Acids Res 2018;46:D754-D761.
Fishilevich S, Nudel R, Rappaport N, et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database J Biol Databases Curation 2017;2017. https://pubmed.ncbi.nlm.nih.gov/28605766/ or https://academic.oup.com/database/article/doi/10.1093/database/bax028/3737828
Nicolas G, Pottier C, Maltête D, et al. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology 2013;80:181-187.
Ramos EM, Oliveira J, Sobrido MJ, Coppola G. Primary familial brain calcification. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews®. Seattle, WA: University of Washington; 1993. http://www.ncbi.nlm.nih.gov/books/NBK1421/. Accessed March 7, 2019.
Nicolas G, Charbonnier C, de Lemos RR, et al. Brain calcification process and phenotypes according to age and sex: lessons from SLC20A2, PDGFB, and PDGFRB mutation carriers. Am J Med Genet Part B Neuropsychiatr Genet 2015;168:586-594.
Grangeon L, Wallon D, Charbonnier C, et al. Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype. Brain J Neurol 2019;142(6):1573-1586.
Wang C, Li Y, Shi L, et al. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet 2012;44:254-256.
Keller A, Westenberger A, Sobrido MJ, et al. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet 2013;45:1077-1082.
Legati A, Giovannini D, Nicolas G, et al. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nat Genet 2015;47:579-581.
Yao X-P, Cheng X, Wang C, et al. Biallelic mutations in MYORG cause autosomal recessive primary familial brain calcification. Neuron 2018;98:1116-1123.e5.
Cen Z, Chen Y, Chen S, et al. Biallelic loss-of-function mutations in JAM2 cause primary familial brain calcification. Brain J Neurol 2020;143(2):491-502.
Ramos EM, Carecchio M, Lemos R, et al. Primary brain calcification: an international study reporting novel variants and associated phenotypes. Eur J Hum Genet 2018;26:1462-1477.
Hozumi I, Kurita H, Ozawa K, et al. Inorganic phosphorus (Pi) in CSF is a biomarker for SLC20A2-associated idiopathic basal ganglia calcification (IBGC1). J Neurol Sci 2018;388:150-154.
Jensen N, Schrøder HD, Hejbøl EK, et al. Mice knocked out for the primary brain calcification-associated gene Slc20a2 show unimpaired prenatal survival but retarded growth and nodules in the brain that grow and calcify over time. Am J Pathol 2018;188:1865-1881.
Baker M, Strongosky AJ, Sanchez-Contreras MY, et al. SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia. Neurogenetics 2014;15:23-30.
David S, Ferreira J, Quenez O, et al. Identification of partial SLC20A2 deletions in primary brain calcification using whole-exome sequencing. Eur J Hum Genet 2016;24:1630-1634.
Grütz K, Volpato CB, Domingo A, et al. Primary familial brain calcification in the “IBGC2” kindred: all linkage roads lead to SLC20A2. Mov Disord 2016;31:1901-1904.
Guo X-X, Su H-Z, Zou X-H, et al. Identification of SLC20A2 deletions in patients with primary familial brain calcification. Clin Genet 2019;96(1):53-60.
Mu W, Tochen L, Bertsch C, Singer HS, Barañano KW. Intracranial calcifications and dystonia associated with a novel deletion of chromosome 8p11.2 encompassing SLC20A2 and THAP1. BMJ Case Rep 2019;12. https://doi.org/10.1136/bcr-2018-228782
Pasanen P, Mäkinen J, Myllykangas L, et al. Primary familial brain calcification linked to deletion of 5′ noncoding region of SLC20A2. Acta Neurol Scand 2017;136:59-63.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-424.
Backenroth D, Homsy J, Murillo LR, et al. CANOES: detecting rare copy number variants from whole exome sequencing data. Nucleic Acids Res 2014;42:e97.
Le Guennec K, Quenez O, Nicolas G, et al. 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression. Mol Psychiatry 2017;22:1119-1125.
Quenez O, Cassinari K, Coutant S, et al. Detection of copy number variations from NGS data using read depth information: a diagnostic performance evaluation. https://hal-normandie-univ.archives-ouvertes.fr/hal-02317979. Accessed November 7, 2019.
Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci 1999;96:9236-9241.
Huggett JF, Foy CA, Benes V, et al. The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments. Clin Chem 2013;59:892-902.
Cassinari K, Quenez O, Joly-Hélas G, et al. A simple, universal, and cost-efficient digital PCR method for the targeted analysis of copy number variations. Clin Chem 2019;65(9):1153-1160.
Carithers LJ, Ardlie K, Barcus M, et al. A novel approach to high-quality postmortem tissue procurement: the GTEx Project. Biopreserv Biobank 2015;13:311-319.
Anheim M, López-Sánchez U, Giovannini D, et al. XPR1 mutations are a rare cause of primary familial brain calcification. J Neurol 2016;263:1559-1564.
López-Sánchez U, Nicolas G, Richard A-C, et al. Characterization of XPR1/SLC53A1 variants located outside of the SPX domain in patients with primary familial brain calcification. Sci Rep 2019;9:6776.
Concordet J-P, Haeussler M. CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Res 2018;46:W242-W245.
Haeussler M, Schönig K, Eckert H, et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol 2016;17:148.
López-Sánchez U, Tury S, Nicolas G, et al. Interplay between PFBC-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis [published online ahead of print, 2020 May 11]. J Biol Chem. 2020; jbc.RA119.011376. https://doi.org/10.1074/jbc.RA119.011376
Nicolas G, Pottier C, Charbonnier C, et al. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain J Neurol 2013;136:3395-3407.
MacDonald JR, Ziman R, Yuen RKC, Feuk L, Scherer SW. The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 2014;42:D986-D992.
Collins RL, Brand H, Karczewski KJ, et al. An open resource of structural variation for medical and population genetics. bioRxiv. https://doi.org/10.1101/578674
Karczewski KJ, Francioli LC, Tiao G, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv. https://doi.org/10.1101/531210
Zarb Y, Weber-Stadlbauer U, Kirschenbaum D, et al. Ossified blood vessels in primary familial brain calcification elicit a neurotoxic astrocyte response. Brain 2019;142:885-902.
Nahar K, Lebouvier T, Andaloussi Mäe M, et al. Astrocyte-microglial association and matrix composition are common events in the natural history of primary familial brain calcification [published online ahead of print September 27, 2019]. Brain Pathol Zurich Switz. https://doi.org/10.1111/bpa.12787
Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. Bio informatics 2009;25(14):1754-1760.
McKenna A, Hanna M, Banks E. The genome analysis toolkit: a map reduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-1303.